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Purpose: The purpose of this study was to validate the commonly accepted indicators of 
risk of ischemic stroke that indicate the necessity for cerebral protection during carotid 
endarterectomy (CEA), and to examine the efficacy of high-dose thiopentone sodium 
(thiopental) as a cerebral protection method in patients who are at high risk of intraop- 
erative ischemic stroke. 
Method: In a prospective study of 37 CEAs performed for symptomatic stenosis >70%, 
functional and clinical indicators of risk of ischemic stroke during carotid cross-clamping 
were identified. Functional indicators of risk were the development of ischemic electro- 
encephalogram (EEG) changes and stump pressure <25 mm Hg. Clinical indicators of 
risk were previous ischemic hemispheric stroke and severe bilateral disease. These indica- 
tors were correlated in all patients, some of whom had two or three coexisting indicators 
of risk. The EEG and stump pressure were monitored continuously during carotid 
occlusion in all operations. Carotid occlusion times were recorded. Intraluminal shunting 
was eliminated in favor of high-dose thiopental cerebral protection in all patients. 
Neurologic outcome was deemed to measure the efficacy of thiopental protection in 
patients who are identified to be at risk and, hence, in need of cerebral protection. The 
validity of the indicators used to identify risk of ischemic stroke during CEA was assessed. 
Results: The absolute stroke risk was found to be 29.7% for the whole group (37 patients) 
and 57.9% in 19 patients who had commonly accepted indications for protective shunt- 
ing. The correlation ofischemic EEG changes with stump pressure <25 mm Hg was only 
27.3%, whereas the expected correlation based on well-documented reports in the 
literature was 100%. The lack of correlation may have been related to the prevention of 
ischemic EEG changes by thiopental. There were no neurologic deficits in the series. 
Conclusions: The absence of neurologic deficit in the study indicated that thiopental 
protection was effective in preventing ischemic stroke in high-risk patients and safely 
replaced intralmninal shunting. (J Vase Surg 1997;25:611-9.) 
It is generally accepted that carotid artery occlu- 
sion during carotid endarterectomy (CEA) may re- 
sult in focal or regional hypoperfusion that in some 
patients may precipitate an ischemic stroke. Since the 
inception of CEA 40 years ago, two major principles 
have been applied to provide protection against isch- 
emic cerebral damage as a result of  hypoperfusion, 
namely, prevention ofhypoperfusion by intraluminal 
shunting and protection of cerebral cells against he 
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effects of ischemia. Intraluminal shunting has been 
the most enduring and widely practiced and has been 
further refined by techniques designed to identify 
those patients who are at risk of ischemic stroke 
during carotid occlusion and to shunt selectively only 
in those patients. In our practice, shunting has been 
abandoned in favor of  routine pharmacologic cere- 
bral protection using high-dose thiopentone so- 
dium (thiopental). l"2 We recently reported our ex- 
perience of  259 CEAs for symptomatic stenosis 
>70% associated with contralateral critical stenosis 
(>70%) or contralateral occlusion; a major stroke 
rate of  0.4% was the product of  one postoperative 
cerebral hemorrhage. 2 In that report, patients who 
had a defined specific risk of  ischemic stroke were 
not identified, and although there were no intra- 
operative ischemic strokes in the series, we were 
unable to state unequivocally that thiopental cere- 
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bral protection safely replaced intraluminal shunt- 
ing in patients who were at risk of intraoperative 
ischemic stroke. To clarify the validity of thio- 
pental cerebral protection, a prospective study 
was undertaken between November 1994 and Sep- 
tember 1995 in 36 consecutive symptomatic pa- 
tients who underwent CEA as a result of stenosis 
>70% in whom the risk of ischemic stroke during 
carotid occlusion was identified. The study was 
based on the premise that the identification of 
ischemic stroke risk during carotid occlusion de- 
mands some form of cerebral protection against 
the effects of hypoperfusion ischemia to prevent 
ischemic stroke. 
PATIENTS AND METHODS 
Definitions 
The term "ischemic stroke" used in the text im- 
plies hemodynamic is hemic stroke that is associated 
with carotid cross-clamping and excludes ischemic 
stroke that results from intraoperative c rebral em- 
bolus or operative site occlusion. 
For purposes of clarity, stump pressure up to and 
including 25 mm Hg is referred to as "stump pres- 
sure <25 mm Hg." 
Patients 
Thirty-six symptomatic patients with docu- 
mented histories of hemispheric transient ischemic 
attacks underwent 37 CEAs. Two patients with cre- 
scendo transient ischemic attacks arrived in the oper- 
ating room for surgery with neurologic deficit, one 
with dysphasia nd the other with hemiparesis. One 
patient underwent bilateral CEA with a period of 8 
weeks between operations. There were 22 men and 
14 women in the study, with ages ranging from 51 to 
83 years (mean, 68.4 years). 
Identification of ischemic stroke risk 
Patients were identified as being at risk of isch- 
emic stroke according to both the functional and 
clinical criteria widely reported in the literature. 
Functional indicators of risk were the development 
of asymmetrical EEG changes appearing with carotid 
cross-clamping, and mean stump pressure <25 mm 
Hg during the carotid occlusion period. Clinical in- 
dicators of risk were a history of previous completed 
ischemic hemispheric stroke, and the presence of 
severe bilateral carotid disease, defined as stenosis 
>70% (the operative lesion) associated with con- 
tralateral stenosis >70%, or contralateral occlusion. 
In addition, carotid occlusion exceeding 25 minutes 
was deemed to constitute increased risk. "Potential 
stroke risk" was defined by the identification ofboth 
clinical and functional indications for intraluminal 
shunting, either alone or in combination. "Absolute 
stroke risk" was defined by the identification ofisch- 
emic electroencephalographic c anges, stump pres- 
sure <25 mm Hg persisting during carotid occlu- 
sion, or both. Patients who were identified to be at 
risk of cross-clamping ischemic stroke, and who thus 
required cerebral protection, were protected uring 
surgery using high-dose thiopental rather than in- 
traluminal shunting. 
Anesthesia nd cerebral protection 
All operations were performed with the patient 
under general anesthesia using thiopental induction 
and an oxygen-nitrous oxide mixture with isoflurane 
for maintenance. High-dose thiopental was used for 
cerebral protection in all patients. Thiopental was 
titrated by hand injection in doses sufficient o pro- 
duce burst-suppression activity on continuous elec- 
troencephalogram (EEG) monitoring, with mini- 
mum interburst intervals of 60 seconds. The total 
dose of thiopental required to produce this burst- 
suppression pattern and maintain it during the ca- 
rotid occlusion period by incremental bolus doses 
varied from 1350 mg to 4000 mg (average, 1800 
mg). Ischemic EEG changes that appeared with 
carotid occlusion were managed by increasing the 
interburst interval to as long as 5 minutes by ad- 
ministration of further bolus doses of thiopental. 
No further thiopental was administered after com- 
pletion of the endarterectomy and clamp release. 
During the period of thiopentaI administration, 
nitrous oxide and isoflurane were discontinued, 
and anesthesia relied on oxygen and thiopental. 
Intraluminal shunts were not used in any of the 
operations. 
Specific intraoperative monitoring 
In all cases the raw EEG was monitored continu- 
ously, using subcutaneous platinum electrodes in a 
10-20 montage, on a Medelec/Teca DG32 electro- 
encephalograph (Medelec Ltd., Surrey, U.K.). EEG 
abnormalities, or changes appearing after carotid 
cross-clamping, were interpreted during monitoring 
in the operating room by a specialist neurophysiolo- 
gist (R. G. H.). Unilateral change in burst activity or 
diminution i  burst amplitude greater than 30% were 
interpreted as ischemic in origin. Systemic arterial 
pressure was monitored continuously via a radial 
artery catheter. Internal carotid artery back pressure 
was monitored continuously during carotid occlu- 
sion (dynamic stump pressure). 
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Fig. 1. Dynamic stump ressure. Simultaneous continuous recording of mean systemic arterial 
pressure (upper recording) and mean stump pressure (lower recording). Stump pressure mirrors 
arterial systemic pressure precisely and varies only when systemic pressure varies. With adminis- 
tration of thiopental bolus doses (arrows) both pressures fall slightly (5 to 10 mm Hg) and 
recover apidly (<1 minute), sometimes requiring 50 to 100 Izg bolus doses of metaraminol 
administered via a computerized syringe infusion pump (58% of cases). Scale: 1 vertical 
division = 5 mm Hg; 1 horizontal division = 24 seconds. MAP, Mean systemic arterial 
pressure; MSP, mean stump pressure; B-V, back-venting of internal carotid artery,; C-R, clamp 
release. 
Dynamic s tump pressure 
Stump pressure was measured using a 4F wedge 
pressure catheter (Arrow International Inc., Read- 
ing, Pa.) connected via a silicon elastic line to a 
pressure transducer. The system was fluid-filled, with 
exclusion of  air bubbles, and connected to a twin- 
channel recorder. The transducer was calibrated for 
zero at the level of  the internal carotid artery. After 
control of  the carotid arteries, the wedge catheter 
was passed via the carotid arteriotomy into the inter- 
nal carotid artery for a distance of 2 cm, and the 
balloon was inflated via a tap to provide occlusion. 
Balloon inflation was maintained by closing the tap. 
A continuous recording of mean stump pressure was 
obtained in parallel with mean systemic arterial pres- 
sure recorded on the second channel (Fig. 1). Spot 
readings were taken at 2-minute intervals and were 
averaged to provide a figure for mean stump pressure 
across the carotid occlusion period. Mean systemic 
arterial pressure was maintained at the pre-thiopental 
level during carotid occlusion using 50 to 100 vtg 
doses of  metaraminol if necessary (58% of cases). 
Postoperat ive care 
All patients were transferred to the intensive care 
unit immediately after surgery and were released to 
the open ward on the morning after surgery (mean, 
22 hours). Recovery from thiopental anesthesia to 
the equivalent of a Glasgow Coma Scale assessment 
of 15 occurred in 30 minutes to 3 hours (mean, 1.9 
hours). Endotracheal intubation varied from 1 to 10 
hours (mean, 2.9 hours). Hospital discharge was on 
the third or fourth day, dictated largely by the timing 
of formal Department ward rounds. The details of 
postoperative care and monitoring have been report- 
ed. 1,2 
Assessment 
The validity of thiopental cerebral protection was 
assessed by the occurrence of transient or permanent 
neurologic deficit. The study also allowed an assess- 
ment of the validity of the indicators used to identify 
the risk ofischemic stroke. 
RESULTS 
Functional indicators o f  ischemic stroke risk 
In the whole group (37 patients) there were 
seven EEG asymmetries and seven stump pressures 
<25 mm Hg identified in 11 patients. EEG asymme- 
try and stump pressure <25 mm Hg coexisted in 
three patients, and four EEG asymmetries and four 
stump pressures <25 mm Hg occurred alone. Of  23 
patients who had no clinical indicators of risk, four 
EEG asymmctries and three stump pressures <25 
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Table I. Potential ischemic stroke risk--37 patients 
Indicators of risk Contralateral carotid disease 
Patients 19 Occlusion (7) Stenosis >70% (5) 
Previous stroke 4 + + + 
Bilateral disease 12 + + + + + + + + + + + + 
EEG changes 7 + + 
Stump pressure 7 (43) (31) 19 24 24 
Occlusion t ime(min.)  35 35 55 53 29 34 53 37 36 44 42 42 31 
Stenosis 
Normal (5) <70% (2) 
+ 
+ + + + + 
25 (28) 25 11 23 
30 54 26 57 44 42 
Stump pressures of  26 to 50 mm Hg were not considered indicators of  risk. Stump pressure not recorded in the table were all >50 mm 
Hg. Average carotid occlusion time was 41 minutes (range, 26 to 57 minutes). Potential stroke risk, 51% (19 of  37). 
Table II. Stroke risk associated with disease 
Disease Patients Risk indicators Absolute risk 
Bilateral 12 5 41.7% 
Unilateral 25 6 24% 
mm Hg were identified in five patients. EEG asym- 
metry corresponded with stump pressure <25 mm 
Hg in two (Table I). 
Clinical indicators of  ischemic stroke risk 
Clinical indicators of risk were identified in 14 
patients. Ten of these had severe bilateral disease, 
two had both bilateral disease and previous ischemic 
stroke, and two had previous ischemic stroke. Seven 
functional indicators of risk, three EEG asymmetries 
and four stump pressures <25 mm Hg, coexisted 
with clinical indicators in six patients. The concur- 
rence of functional with clinical indicators of risk was 
43% (6 of i4; Table I). 
Comparison of  bilateral and unilateral disease 
Functional indicators of risk were identified in 
five of 12 patients with severe bilateral disease 
(41.7%) and in six of 25 patients with unilateral 
disease (24%; Table II). 
Ischemic stroke risk 
A potential ischemic stroke risk, as defined fbr 
this study, indicated the necessity for cerebral protec- 
tion against ischcmia in 19 of the 37 patients (51%). 
In these 19 patients carotid occlusion time averaged 
41 minutes (range, 26 to 57 minutes), and 11 of the 
i9 had multiple (two or three) indicators of risk 
(Table I). The absolute ischemic stroke risk, as de- 
fined for this study, in the 19 patients who had 
commonly accepted indications for protective shunt- 
ing was 57.9% (11 of 19). In these 11 patients ca- 
rotid occlusion time averaged 37 minutes (range, 26 
to 57 minutes). For the whole group the absolute 
ischemic stroke risk was 29.7% (11 of 37; Table I). 
The potential risk was almost certainly higher be- 
cause of the long carotid occlusion times and the 
possibility of the failure to detect some ischemic EEG 
changes prevented by thiopental. If no effective cere- 
bral protection was used, an intraoperative ischemic 
stroke rate of at least 29.7% could reasonably have 
been expected in the whole group, with stroke pre- 
dominating in those who had accepted indications 
for protective shunting, in whom a stroke rate of 
57,9% could have been anticipated. All patients in 
the study were symptomatic with >70% stenosis, and 
it is now well recognized that symptomatic patients 
are at greater isk of stroke than are asymptomatic 
patients. 3,4 Although this study has not specifically 
assessed other risk factors uch as systemic hyperten- 
sion, cardiac disease, and cerebrovascular disease, 
such factors did in fact coexist in a number of the 
patients. Clearly, the patients in this study represent 
an extremely high-risk group for perioperative 
stroke. 
Neurologic outcomes 
There were no neurologic deficits, transient or 
permanent, in the series. Both patients who were 
admitted for operation with neurologic deficit made 
full recoveries within 24 hours after surgery. 
DISCUSSION 
Hemodynamic ischemic stroke results from a 
critical reduction of cerebral blood flow. Much of the 
practice of CEA revolves around the prevention of 
ischemia ssociated with hypopeffusion by maintain- 
ing blood flow with an intraluminal shunt. Tech- 
niques that are designed to detect reduced cerebral 
blood flow during surgery, and thus indicate apoten- 
tial risk of ischemic stroke, have allowed selective 
shunting in those patients identified to be at risk. The 
development during carotid occlusion for CEA of 
ischemic EEG changes, neurologic symptoms or 
signs in the awake patient, and stump pressures <25 
mm Hg, have been investigated and correlated with 
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cerebral blood flow and are the commonly used indi- 
cators of risk and thus for intraluminal shunting. In 
some centers, selective shunting is based on the clin- 
ical criteria of severe bilateral disease and previous 
completed hemispheric stroke without supporting 
evidence of decreased cerebral blood flow. The alter- 
native to shunting is to provide protection against 
the effects of reduced blood flow at the neuronal 
cellular level or to enhance blood flow in an ischemic 
area by pharmacologic or physiologic means. 
Risk of  ischemic stroke 
The risk of ischemic stroke during CEA has not 
bccn clearly defined, although ischemia during ca- 
rotid occlusion has bccn widely investigated. Studies 
that correlate ischemic hanges detected by monitor- 
ing (ischemic EEG changes, neurologic symptoms or 
signs in the awake patient, and low stump pressures) 
with cerebral blood flow indicate a potential risk for 
ischemic stroke during carotid occlusion across the 
spectrum ofcxtracranial vascular disease of as high as 
48% when patients with contralateral occlusion are 
singled out .  5,6 This does not mean that ischemic 
stroke will inevitably occur unless a shunt or some 
other tbrm of cerebral protection is used, because 
such ischemia may be detectable by monitoring 
within a range of cerebral blood flow reduction from 
24 ml/100 gm/min down to 10 ml /100 gin/rain 
and not cause permanent ischemic ncuropathologic 
damage. 7,8 The risk of stroke, theretbrc, does not 
necessarily equate with the incidence of ischemic 
changes detected by monitoring. However, Kass et 
al. 9 have demonstrated that the development ofneu- 
ronal cellular changes associated with cell death (so- 
dium and calcium influx and potassium etBux) is 
related to the duration of ischemia. Prolonged cross- 
clamping, as in the patients in this study, may also, 
therefore, be an important determinant of risk and, 
within the range of blood flow reduction producing 
ischemic EEG changes (24 to 10mls/100 gm/min),  
the risk of permanent ncurologic damage is likely to 
increase with prolonged clamp times. Ferguson, m 
equating risk of ischemic stroke with intraoperative 
stroke, has established a risk of 1.4% in nonshuntcd 
and otherwise unprotected patients, and identified 
patients with severe EEG changes and stump pres- 
sures <25 mm Hg as being at high risk ofhcmody- 
namic ischemic stroke. Risk determined across the 
full spectrum of patients ubjected to CEA does not 
equate with risk in an individual patient. In some 
patients there may be no risk ofischemic stroke, and, 
in others, such as Ferguson's l° group with severe 
EEG changes and stump pressure <25 mm Hg, the 
risk may approximate 100%. It is clear that there is 
little or no validity in equating the risk of ischemic 
stroke with the intraoperative stroke rates in groups 
of patients who arc submitted to operation with a 
wide diversity in symptoms and severiw of disease. 
The risk of  hemodvnamic ischemic stroke during 
CEA exists only when carotid cross-clamping pro- 
duccs a critical reduction of cerebral blood flow, can 
be determined only tbr each individual patient, and 
can only be defined by and equated with a demon- 
strated reduction of cerebral blood flow. Functional 
indicators of reduced cerebral blood flow are, there- 
tbre, the only valid indicators of risk of ischcmic 
stroke. 
Stroke risk associated with cerebral protection 
The prevention of ischemic stroke is essential for 
successful CEA and provides the rationale for intralu- 
minal shunting or some other form of intraoperative 
cerebral protection. It is axiomatic that any cerebral 
protection method must prevent ischemic stroke and 
carry no inherent risk of stroke. Analysis of routinely 
shunted patients provides no direct indication of  the 
stroke-prevention capability of shunting because pa- 
tients who are at definite risk of ischemic stroke 
during carotid cross-clamping are not identified. 
However, excellent results have been reported in 
routinely shunted patients, with stroke rates between 
1.1% and 1.4%, ~ 13 well within the acceptable prac- 
tice guidelines recently advised by Moore et al. 3 Such 
results from centers of  recognized excellence with 
experience of large numbers of operations are well 
below the stroke rates achieved in the majority of 
centers that perform CEA ~4a5 and provide indirect 
evidence that shunting must prevent some ischemic 
strokes. Riles ctal.  16 have demonstrated improving 
stroke rates with increasing experience of shunting, 
which suggests that technical familiarity with shunt- 
ing can result in reduction of stroke rate. This may 
indicate that shunting has an inherent stroke risk, 
albeit small, related to limited technical experience. 
Selective shunting is specifically based on the 
identification of patients who are believed to be at 
risk and provides amodel tbr the study of  the efficacy 
of intraluminal shunting in the prevention of isch- 
cmic stroke. If shunting removes the risk of operative 
ischcmic stroke and has no inherent risk, then stroke 
rates and pathologic stroke profiles in any one cohort 
of selectively shunted patients hould be similar in 
both shunted and nonshunted patients. Stroke rates 
in the nonshunted patients in the selectively shunted 
series for same surgeons and same institutions re- 
corded in Table II117-22 fall well within the accepted 
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Table I lL  Stroke rates in selectively 
shunted series 
Factorial 
in crease 
Patients No with 
Author (n) Ch,erall shunt Shunt shunt 
Davies et al. 17 389 ~ 2.5% 1.1% 6.5% 5.9 
Archie is 665 0.8% 0.2% 5.2% 26.00 
Fr iedman et al. 19 145 6.3% 3.7% 14% 3.78 
Mackey et al. z° 598 2.8% 2.3% 5% 2.17 
Perler et al. 21 205 3.9% 2.1% 5.4% 2.57 
Graham et al. 22 212 3.3% 2.0% 6.3% 3.15 
practice guidelines 3 and indicate that the surgeons 
involved were technically competent and capable of 
above-average r sults as recently defined by Rothwell 
et al. 4 (stroke rates of 2.51% for asymptomatic dis- 
ease and 4.28% for symptomatic disease). Across 
these series the shunted patients, compared with the 
nonshunted, sustained stroke rates increased by mul- 
tiples of 5.90, 26, 3.78, 2.17, 2.57, and 3.15, respec- 
tively, despite apresumably constant level of surgical 
experience and technical ability. In a multicenter 
transcranial Doppler study reported by Halsey 23 that 
assessed stroke associated with shunting in patients 
without evidence of cross-clamping ischemia, 
shunted patients ustained a 6.3 multiple increase in 
stroke rate over nonshunted patients (4.4% vs 0.7%). 
The argument that a higher stroke rate is to be 
expected in selectively shunted patients because they 
are identified to be at risk ofischemic stroke is invalid 
and unsustainable if shunting removes the threat of 
ischemia. It is difficult to attribute the higher stroke 
rate with shunting in the series in Table III to any- 
thing other than the shunt, either because of techni- 
cal failure of shunt flow, damage to the vessels, em- 
bolization through the shunt, or, most likely, 
imposition of the shunt in the operative field pre- 
venting adequate ndarterectomy. It would seem 
that shunting does carry an inherent stroke risk de- 
spite good surgical technique and therefore isnot an 
ideal protection method. Elimination of shunting, 
with its inherent stroke risk, could be expected to 
reduce perioperativc stroke rates provided ischemic 
damage was prevented by some other effective pro- 
tection method. However, any reduction in stroke 
rate by replacement of shunting with some other 
effective protection method is likely to be marginal in 
centers of technical expertise and wide experience of 
shunting but may possibly achieve some significance 
in centers of limited experience or in centers where 
shunting isused infrequently on a selective basis. 
In this study, intraluminal shunting was replaced 
by routine high-dose thiopental cerebral protection, 
and ischcmic EEG changes and low stump pressures 
were detected after cerebral protection had been 
implemented. In our experience of 1135 operations 
using this technique (1060 CEAs and 75 complex 
arch and great vessel reconstructions), in which the 
causes of neurologic deficit have been documented 
prospectively by neurologic examination, operative 
technique review, computed tomographic cerebral 
scanning, carotid duplex scanning, and autopsy, 
there have been no neurologic deficits, transient or 
permanent, hat could be attributed to the use of 
high-dose thiopental. There are no reports in the 
experimental or clinical literature that suggest that 
thiopental carries an inherent risk of stroke. Pharma- 
cologic thiopcntal cerebral protection, unlike shunt- 
ing, therefore represents an ideal protection method 
provided it effectively protects against, or minimizes, 
ischemic erebral neuronal damage. Both the exper- 
imental 14-27 and clinical 1,2,2s,29 literature indicate 
that thiopental does provide such protection. 
Functional indicators of  ischemic stroke risk 
Ferguson, 1°Moore and Hall, 3° and Hobson et 
al.31 have all demonstrated that stump pressure <25 
mm Hg is an accurate indicator of ischemic stroke 
risk because such pressures occur inside the critical 
range of cerebral blood flow reduction (18 to 10 
mls/100 gm/min). Importantly, they also demon- 
strated a 100% correlation between ischemic EEG 
changes and stump pressures <25 mm Hg. This 
combination, ischemic EEG change with stump 
pressure <25 mm Hg, would seem to represent the 
most accurate indicator of risk ofischemic stroke. In 
the current study there were seven patients who had 
stump pressure <25 mm Hg. However, the correla- 
tion between ischemic EEG changes and stump res- 
sure <25 mm Hg was only 43% (3 of 7). The lower 
correlation between ischemic EEG changes and 
stump pressure <25 mm Hg may well be related to 
the prevention of ischemia, and hence of ischemic 
EEG changes, by thiopental at the neuronal level 
without any corresponding effect on stump pressure. 
The study also indicates that when stump pressure is
<25 mm Hg, indicating critical reduction of cerebral 
blood flow, ischcmic EEG changes may persist de- 
spite the effects of thiopental. Because there were no 
ncurologic deficits, thiopental would appear to pro- 
vide protection against ischemic stroke in the face of 
critical blood flow reduction associated with persis- 
tent ischemic EEG changes and stump pressure <25 
mm Hg. 
The development ofischemic EEG changes dur- 
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ing carotid cross-clamping has been shown to have a 
high correlation (above 90%) with decreased cerebral 
blood flow. s,3°,32 Such changes can occur with stump 
pressures outside the range indicating critical reduc- 
tion of flow (i.e. above 25 mm Hg). McKay et al., 32 
in an excellent study correlating ischemic EEG 
changes and low stump pressures with cerebral blood 
flow, found a 46% correlation between ischemic EEG 
changes and stump pressures <50 mm Hg. Some of 
these changes were seen outside the range of critical 
reduction of flow indicated by stump pressure <25 
mm Hg. In the current study, two patients had 
ischemic EEG changes with stump pressures be- 
tween 26 mm Hg and 50 mm Hg (43 mm Hg and 
28 mm Hg) and two with stump pressure >50 mm 
Hg. In this situation it may be that the changes are 
related to focal or regional ischemia ssociated with 
intracerebral rterial disease, rather than global re- 
duction of cerebral blood flow associated with cross- 
clamping and reflected in stump pressure <25 mm 
Hg. It would seem safest to consider such EEG 
changes as indicating risk of ischemic stroke. The 
protective ffect of thiopental may also have pre- 
vented the appearance of ischemic EEG changes in 
some patients with stump pressures >25 mm Hg. 
It would seem that if stump pressure is used in 
isolation to detect risk, stump pressure <25 mm Hg 
will fail to identify some patients at risk who have 
pressures >25 mm Hg, and stump pressure <50 mm 
Hg will overidentify some patients not at risk who 
have pressures of 26 to 50 mm Hg and will fail to 
identify some patients at risk with pressures >50 mm 
Hg. Reliance on stump pressure measurement may 
thus result in higher stroke rates because of failure to 
identify all patients at risk and unnecessary shunting 
in others. Furthermore, the technique commonly 
used to measure stump pressure relies on clamping of 
the common and external carotid arteries with a 
patent internal carotid artery and may carry an inher- 
ent risk of embolization. The technique for stump 
pressure measurement described here eliminates this 
risk. Stump pressure measurement, as an indicator of 
stroke risk and for protective shunting, is clearly less 
than ideal and is invalid as a universal indicator of 
risk. 
Although we have not been able to assess the 
awake patient, the occurrence of clinical symptoms 
or signs in the awake patient has been shown to 
almost invariably correlate with ischemic EEG 
changes 33 and therefore represents a valid indicator 
of the presence ofischemia during carotid occlusion. 
Its value as an indicator of  risk of  ischemic stroke 
and of the need for protective shunting is thus 
similar to that of  the development of  ischemic 
EEG changes. 
Clinical indicators o f  ischemic stroke risk 
Clinical indicators of the risk of ischemic stroke 
bear no direct relationship to critical reduction of 
cerebral blood flow and cannot be universally re- 
garded as valid indicators of risk. Obviously, some 
patients will have critical reduction of flow but can 
only be identified by the development of functional 
changes that indicate reduction of flow with cross- 
clamping. In this study, six of the 14 patients with 
clinical indicators of risk developed functional indica- 
tors of risk: ischemic EEG changes alone (2), stump 
pressure <25 mm Hg alone (3), and both ischemic 
EEG changes and stump pressure <25 mm Hg (1). 
The correlation was 43% (6 of 14). Again, some 
ischemic EEG changes may have been prevented by 
thiopental. Nevertheless, it is clear that clinical indi- 
cations tbr protection are by no means accurate and 
are likely to result in unnecessary shunting with its 
potential for increasing perioperative stroke rates. 
Risk associated with severity o f  disease 
This study has identified a potential risk of isch- 
emic stroke of 41.7% in patients who have severe 
bilateral disease compared with 24% in patients who 
have predominantly unilateral disease (Table II). 
This finding supports the commonly held perception 
that patients who have severe bilateral disease are at 
greater isk of ischemic stroke, and it is common 
practice to offer such patients cerebral protection. We 
have reported a 0.4% major stroke rate in 259 pa- 
tients with severe bilateral disease using thiopental 
protection, 2 and we have also indicated that when 
such protection is used during surgeu, patients who 
have severe bilateral disease are not at increased risk 
of stroke compared with patients who have unilateral 
disease? Other investigators, using intraluminal 
shunting for protection, have also reported that pa- 
tients who have severe bilateral disease are not at 
increased risk during protected surgery. 2°'21'34 It 
would seem, therefore, that shunting and thiopental 
protection both offer effective protection against 
ischemic stroke. 
CONCLUSION 
The literature generally concedes that there is a 
risk of ischemic stroke during carotid occlusion for 
endarterectomy. Patients with previous troke associ- 
ated with ipsilateral internal carotid occlusions, se- 
vere bilateral disease, ischemic EEG changes with 
clamping, and low stump pressures have been selec- 
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tively identified as being at risk and as requiring 
cerebral protection against ischemia. The 19 patients 
reported here, with commonly accepted indications 
for protective shunting, all fall into one of these risk 
categories with multiple (2 or 3) risk categories in 
more than half of them. An absolute risk of  ischemic 
stroke was identified in 11, for an expected stroke 
rate of 57.9% (11 of 19) if no cerebral protective 
measures were used, particularly with the average 
carotid occlusion time of 41 minutes. There were no 
neurologic deficits. If the described risk factors and 
the indications for the need for cerebral protection 
are indeed valid, then the absence of perioperative 
stroke indicates that thiopental protection has pro- 
vided effective and safe protection against ischemic 
stroke. If, however, thiopental has not provided ef- 
fective cerebral protection, then ischemic EEG 
changes and stump pressure <25 mm Hg that persist 
during carotid occlusion, as indicators of  ischemic 
stroke risk and the need for cerebral protection, can 
be dismissed as invalid and protection itself dismissed 
as unnecessary. Such a conclusion cannot be sus- 
tained under the weight of evidence to the contrary, 
widely documented in the literature. 
This study, therefore, allows the conclusion that 
thiopental cerebral protection prevents intraopera- 
tive ischemic stroke, safely replaces intraluminal 
shunting as a means of ischemic stroke prevention 
during CEA, and has no inherent stroke risk. There- 
fore, thiopental protection may be preferable to 
shunting with its inherent risk, and consequently, to 
techniques uch as awake patient monitoring under 
local cervical block anesthesia and stump pressure 
measurement, which are designed to indicate the 
necessity for shunting. 
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